Luise Holzhauser1, Gene Kim1, Gabriel Sayer1, Nir Uriel2. 1. Department of Medicine, Division of Cardiology, University of Chicago, Chicago, IL, USA. 2. Department of Medicine, Division of Cardiology, University of Chicago, Chicago, IL, USA. nuriel@medicine.bsd.uchicago.edu.
Abstract
PURPOSE OF REVIEW: Left ventricular assist device (LVAD) therapy serves as mainstay therapy for bridge to transplantation and destination therapy. Evidence is now mounting on the role of LVAD therapy as bridge to recovery. In the current review, we will summarize the data on biomarkers of myocardial recovery following LVAD implantation. RECENT FINDINGS: Myocardial recovery can occur spontaneously, following pharmacological intervention and in the setting of mechanical circulatory support such as LVAD. Several biomarkers such as B-type natriuretic peptide (BNP), N-terminal pro B-type natriuretic peptide (NT-proBNP), ST2, etc. have been identified and are being used to guide medical therapy in heart failure (HF) patients. However, recent data raised concern that those biomarkers may not be helpful in managing heart failure patients in general, and as such questioned their use in the advanced heart failure population. At this point, the use of biomarker to identify patients with myocardial recovery during LVAD support has not been established, and LVAD explantation remains a decision driven by echocardiographic and hemodynamics improvement. HF biomarkers in monitoring myocardial and neurohormonal activation response to mechanical unloading and medical therapy could be valuable. However, at this time, there is inadequate evidence to select a single or a set of HF biomarkers to reliably identify patients bridged to recovery for LVAD explantation.
PURPOSE OF REVIEW: Left ventricular assist device (LVAD) therapy serves as mainstay therapy for bridge to transplantation and destination therapy. Evidence is now mounting on the role of LVAD therapy as bridge to recovery. In the current review, we will summarize the data on biomarkers of myocardial recovery following LVAD implantation. RECENT FINDINGS: Myocardial recovery can occur spontaneously, following pharmacological intervention and in the setting of mechanical circulatory support such as LVAD. Several biomarkers such as B-type natriuretic peptide (BNP), N-terminal pro B-type natriuretic peptide (NT-proBNP), ST2, etc. have been identified and are being used to guide medical therapy in heart failure (HF) patients. However, recent data raised concern that those biomarkers may not be helpful in managing heart failurepatients in general, and as such questioned their use in the advanced heart failure population. At this point, the use of biomarker to identify patients with myocardial recovery during LVAD support has not been established, and LVAD explantation remains a decision driven by echocardiographic and hemodynamics improvement. HF biomarkers in monitoring myocardial and neurohormonal activation response to mechanical unloading and medical therapy could be valuable. However, at this time, there is inadequate evidence to select a single or a set of HF biomarkers to reliably identify patients bridged to recovery for LVAD explantation.
Authors: Robin A P Weir; Ashley M Miller; Grace E J Murphy; Suzanne Clements; Tracey Steedman; John M C Connell; Iain B McInnes; Henry J Dargie; John J V McMurray Journal: J Am Coll Cardiol Date: 2010-01-19 Impact factor: 24.094
Authors: Tariq Ahmad; Teresa Wang; Emily C O'Brien; Marc D Samsky; John A Pura; Yuliya Lokhnygina; Joseph G Rogers; Adrian F Hernandez; Damian Craig; Dawn E Bowles; Carmelo A Milano; Svati H Shah; James L Januzzi; G Michael Felker; Chetan B Patel Journal: JACC Heart Fail Date: 2014-11-12 Impact factor: 12.035
Authors: Tibor Kempf; Stephan von Haehling; Timo Peter; Tim Allhoff; Mariantonietta Cicoira; Wolfram Doehner; Piotr Ponikowski; Gerasimos S Filippatos; Piotr Rozentryt; Helmut Drexler; Stefan D Anker; Kai C Wollert Journal: J Am Coll Cardiol Date: 2007-08-24 Impact factor: 24.094
Authors: Jozef Bartunek; Leen Delrue; Frederik Van Durme; Olivier Muller; Filip Casselman; Bart De Wiest; Romaric Croes; Sofie Verstreken; Marc Goethals; Herbert de Raedt; Jaydeep Sarma; Lija Joseph; Marc Vanderheyden; Ellen O Weinberg Journal: J Am Coll Cardiol Date: 2008-12-16 Impact factor: 24.094
Authors: Hendrik Milting; Peter Ellinghaus; Michael Seewald; Hamdin Cakar; Birte Bohms; Astrid Kassner; Reiner Körfer; Martina Klein; Thomas Krahn; Lothar Kruska; Aly El Banayosy; Frank Kramer Journal: J Heart Lung Transplant Date: 2008-06 Impact factor: 10.247
Authors: Rudolf A de Boer; Dirk J A Lok; Tiny Jaarsma; Peter van der Meer; Adriaan A Voors; Hans L Hillege; Dirk J van Veldhuisen Journal: Ann Med Date: 2010-12-28 Impact factor: 4.709
Authors: Mohammed Quttainah; Vineesh Vimala Raveendran; Soad Saleh; Ranjit Parhar; Mansour Aljoufan; Narain Moorjani; Zohair Y Al-Halees; Maie AlShahid; Kate S Collison; Stephen Westaby; Futwan Al-Mohanna Journal: Biomolecules Date: 2022-05-23